Analytical performance validation of aPROMISE platform for prostate tumor burden, index and dominant tumor assessment with 18F-DCFPyL PET/CT. A pilot study

Analytical performance validation of aPROMISE platform for prostate tumor burden, index and dominant tumor assessment with 18F-DCFPyL PET/CT. A pilot study

Abstract To validate the performance of automated Prostate Cancer Molecular Imaging Standardized Evaluation (aPROMISE) in quantifying total prostate disease burden with 18F-DCFPyL PET/CT and to evaluate the interobserver and histopathologic concordance in the establishment of dominant and index tumo...

Full description

Bibliographic Details
Main Authors: Ana María García Vicente, Cristina Lucas Lucas, Julián Pérez-Beteta, Pablo Borrelli, Laura García Zoghby, Mariano Amo-Salas, Ángel María Soriano Castrejón
Format: Article
Language:English
Published: Nature Portfolio 2024-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-53683-z

Internet

https://doi.org/10.1038/s41598-024-53683-z

Similar Items